Correction: Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling (Oncogene, (2021), 40, 11, (1974-1987), 10.1038/s41388-021-01682-z)

Lu Wang, Liang Du, Xiao Xiong, Yusheng Lin, Jianlin Zhu, Zhimeng Yao, Shuhong Wang, Yi Guo, Yuping Chen, Kyla Geary, Yunlong Pan, Fuyou Zhou, Shegan Gao, Dianzheng Zhang, Sai Ching Jim Yeung, Hao Zhang

    Research output: Contribution to journalComment/debatepeer-review

    1 Scopus citations

    Abstract

    Only after the article was published online did the authors notice the misspelling of the second author’s name. It should be “Liang Du” instead of “Du Liang”. The authors sincerely apologize for any inconvenience this might have caused. The original article has been corrected.

    Original languageEnglish (US)
    Pages (from-to)5356
    Number of pages1
    JournalOncogene
    Volume40
    Issue number34
    DOIs
    StatePublished - Aug 26 2021

    ASJC Scopus subject areas

    • Molecular Biology
    • Genetics
    • Cancer Research

    Fingerprint

    Dive into the research topics of 'Correction: Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling (Oncogene, (2021), 40, 11, (1974-1987), 10.1038/s41388-021-01682-z)'. Together they form a unique fingerprint.

    Cite this